According to information presented at a GIC board meeting Thursday, in August 2022, the GIC had 798 non-Medicare members using GLP-1 drugs for weight loss and 2,559 for diabetes, costing GIC $4.2 million
For example, in a recent study, menopausal women with obesity or overweight lost more weight when tirzepatide was used along with HRT, and they had better cardiometabolic outcomes
It does not guarantee outcomes, and it should not be interpreted as a promise that a specific peptide will improve sleep, body composition, recovery, or performance in every patient
Managing side effects at each dosage level Side effects are the primary reason people abandon semaglutide before reaching their weight loss goals
Drug screen to determine senolytic activity of electrophilic compounds We screened 10,480 electrophilic compounds from the covalent screening library (CSL-10480-10-Y-10, Enamine)